Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | PRKCA | P17252 | 5/20 | 0.54 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.54 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.54 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | DGKA | P23743 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL368664 | 1.00 | MAPT (0.62) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL9958966 | 1.00 | MAPT (0.62) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL367858 | 1.00 | MAPT (0.62) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL369084 | 0.91 | PRKCA (0.60) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL371296 | 0.91 | PRKCA (0.60) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL371275 | 0.91 | PRKCA (0.60) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL26602804 | 0.91 | PRKCA (0.60) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL369798 | 0.91 | PRKCA (0.60) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL369784 | 0.91 | PRKCA (0.60) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL371177 | 0.88 | MAPT (0.55) | MAPTMAPK1LMNAPRKCAPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113873998-A | Liposome formulations and methods of use and preparation thereof | 糖胺公司 | 2021-12-31 | — | — | CN | claimed |
| WO-2015036044-A1 | CATIONIC LIPID VEHICLES FOR DELIVERY OF TLR7 AGONISTS FOR SPECIFIC TARGETING OF HUMAN CD14+ MONOCYTES IN WHOLE BLOOD | TELORMEDIX SA (CH) | 2015-03-19 | — | — | WO | claimed |
| US-20150079155-A1 | Cationic Liposomal Drug Delivery System for Specific Targeting of Human CD14+ Monocytes in Whole Blood | BIONEER A/S (DK) | 2015-03-19 | — | — | US | claimed |
| EP-2825158-A1 | CATIONIC LIPOSOMAL DRUG DELIVERY SYSTEM FOR SPECIFIC TARGETING OF HUMAN CD14+ MONOCYTES IN WHOLE BLOOD | Bioneer A/S (DK) | 2015-01-21 | — | — | EP | claimed |
| WO-2013135800-A1 | CATIONIC LIPOSOMAL DRUG DELIVERY SYSTEM FOR SPECIFIC TARGETING OF HUMAN CD14+ MONOCYTES IN WHOLE BLOOD | BIONEER A/S (DK) | 2013-09-19 | — | — | WO | claimed |
| EP-2638896-A1 | Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood | Bioneer A/S (DK) | 2013-09-18 | — | — | EP | claimed |
| CN-111867634-B | Enhancement of translocation of micro/nanoparticles across mucus layers using alginate oligomers | 阿尔吉法玛公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-117940563-A | Improved small RNA purification process | 米尔纳格林有限责任公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20230390316-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE | UNIVERSITY OF SOUTH AUSTRALIA (AU) | 2023-12-07 | — | — | US | disclosed |
| WO-2023205628-A1 | LIPID NANOPARTICLES, NUCLEIC ACIDS, AND METHODS OF USE | CITY OF HOPE (US) | 2023-10-26 | — | — | WO | disclosed |
| EP-4134432-A1 | IMPROVED METHOD FOR SMALL RNA PURIFICATION | Mirnagreen S.r.l. (IT) | 2023-02-15 | — | — | EP | disclosed |
| CN-114729336-A | Cell-free composition for ATP regeneration and use thereof | 百奥堪引赛股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| US-20220204967-A1 | METHODS FOR EXTRACTING BIOACTIVE SMALL RNAS FROM PLANTS AND MUSHROOMS | MIRNAGREEN S.R.L. (IT) | 2022-06-30 | — | — | US | disclosed |
| US-20090120874-A1 | MEMBRANE FOR FILTERING OF WATER | AQUAPORIN A/S (DK) | 2009-05-14 | — | — | US | disclosed |
| US-20090007555-A1 | Biomimetic Water Membrane Comprising Aquaporins Used in the Production of Salinity Power | AQUAPORIN A/S (DK) | 2009-01-08 | — | — | US | disclosed |
| EP-1937395-A1 | BIOMIMETIC WATER MEMBRANE COMPRISING AQUAPORINS USED IN THE PRODUCTION OF SALINITY POWER | Aquaporin APS (DK) | 2008-07-02 | — | — | EP | disclosed |
| EP-1885477-A2 | MEMBRANE FOR FILTERING OF WATER | Aquaporin APS (DK) | 2008-02-13 | — | — | EP | disclosed |
| WO-2007033675-A1 | BIOMIMETIC WATER MEMBRANE COMPRISING AQUAPORINS USED IN THE PRODUCTION OF SALINITY POWER | AQUAPORIN APS (DK) | 2007-03-29 | — | — | WO | disclosed |
| WO-2006122566-A2 | MEMBRANE FOR FILTERING OF WATER | AQUAPORIN APS (DK) | 2006-11-23 | — | — | WO | disclosed |
| CN-1387503-A | Hydroxyeicosatetraenoate salts, composition and method of use in treating dry eye disorders | ALCON UNIVERSAL LTD (CH) | 2002-12-25 | — | — | CN | disclosed |